Association of preoperative neoplasia and rectal cuff inflammation on initial pouchoscopy with subsequent neoplasia development in inflammatory bowel disease patients with an ileal pouch-anal anastomosis: a case-control study

COMMENTED

Inflammatory Bowel DiseaseFurther Publications

A Prospective Interventional Study to Evaluate the Effect of Hypoxia on Healthy Volunteers and Patients With Inflammatory Bowel Disease: The Altitude Inflammatory Bowel Disease Study

★ 3 Recommended and commented by Prof. Dr Stephan Vavricka, Faculty Member

Am J Gastroenterol

Vavricka SR, Zeitz J, Madanchi M, Ruiz PA, Biedermann L, Morsy Y, Yilmaz B, Scharl M, Scharl S, Gassmann M, Lutz TA, Kunz A, Bron D, Misselwitz B, MacPherson AJ, Rogler G, Greuter T

doi: 10.14309/ajg.0000000000003888

Inflammatory Bowel Disease

Gut Mycobiome in Inflammatory Bowel Disease: A Systematic Review of Case-Control Studies

Inflamm Bowel Dis

Füchtbauer JD, Brovkina O, Sivickis K, Aalykke C, Høivik ML, Andersen V, Halfvarson J, Bang C, Franke A, Kjeldsen J

doi: 10.1093/ibd/izaf217

Inflammatory Bowel Disease

A Real-World Longitudinal Case-Study Implementing Digital Screening and Treatment for Distress in Inflammatory Bowel Disease: The COMPASS-IBD Patient Journey

Inflamm Bowel Dis

Jones ASK, Seaton N, Harding S, Duff A, Hudson J, Wroe A, Norton S, Singh H, Onih J, Moss-Morris R

doi: 10.1093/ibd/izaf259

Inflammatory Bowel Disease

Higher body mass index is associated with lower drug concentrations in patients with inflammatory bowel disease treated with ustekinumab but not vedolizumab

Inflamm Bowel Dis

Lee J, Porth R, Saraga A, Gade A, Deyhim T, Soliman M, Moini SH, Zullow S, Rabinowitz L, Grossberg L, Cheifetz AS, Papamichael K

doi: 10.1093/ibd/izag139

Inflammatory Bowel Disease

Clinical Response for 12 Months or More to the First Advanced Therapy is Associated with a Significant Decrease in the Long-Term Risk of Hospitalization: A Nation-Wide Analysis of Patients From the UK Inflammatory Bowel Disease (IBD) BioResource

Inflamm Bowel Dis

Yan K, Vuyyuru SK, Taylor A, Figueredo G, Raine T, Sanon M, Naessens D, Munje C, Moran GW

doi: 10.1093/ibd/izaf276

Inflammatory Bowel Disease

Clinical Outcome After Entero-Enteric Anastomosis for Crohn's Disease: A Case-Control Study

J Crohns Colitis

Neri B, Schiavone SC, Mancone R, Fiorillo M, Fonsi A, Calabrese E, Perugini L, Piccione G, Di Matteo FM, Marafini I, Lolli E, Sica GS, Monteleone G, Biancone L

doi: 10.1093/ecco-jcc/jjaf163

Inflammatory Bowel Disease

Effectiveness, Durability, and Safety of Ustekinumab in Inflammatory Bowel Disease: Results from the Taiwan Multicenter Real-world Ustekinumab Study (T-RUST Study)

Inflamm Bowel Dis

Lin SH, Kuo CJ, Chuang CH, Chang CW, Chung CS, Chou JW, Huang TY, Yen HH, Tsai TJ, Lin CP, Chang CH, Tai CM, Tai WC, Yao CC, Chen CC, Pan YB, Le PH

doi: 10.1093/ibd/izag150

Inflammatory Bowel Disease

Efficacy, safety, and outcomes of endoscopic submucosal dissection for inflammatory bowel disease-associated colorectal neoplasia: a systematic review and meta-analysis comparing Asian and Western outcomes

J Crohns Colitis

Martins M, Nunes MV, Macedo G, Pioche M, Jacques J, Geyl S, Shimamura Y, Marques M, Lopes S, Cr Nunes A, Faria-Ramos I, Calabrese G, Sferrazza S, Rimondi A, Murino A, Despott E, De Sire R, Maselli R, Santos-Antunes J, Sousa-Pinto B, Morais R

doi: 10.1093/ecco-jcc/jjag082

Inflammatory Bowel Disease

Serious infections in patients with inflammatory bowel disease and corticosteroids: A propensity score-matched study

Clin Gastroenterol Hepatol

Forss A, Axelrad J, Söderling J, Mårild K, SWIBREG study group, Grip O, Hreinsson JP, Halfvarson J, Naucler P, Ludvigsson JF, Olén O

doi: 10.1016/j.cgh.2026.08.019

Related content

A Prospective Interventional Study to Evaluate the Effect of Hypoxia on Healthy Volunteers and Patients With Inflammatory Bowel Disease: The Altitude Inflammatory Bowel Disease Study

Gut Mycobiome in Inflammatory Bowel Disease: A Systematic Review of Case-Control Studies

A Real-World Longitudinal Case-Study Implementing Digital Screening and Treatment for Distress in Inflammatory Bowel Disease: The COMPASS-IBD Patient Journey

Higher body mass index is associated with lower drug concentrations in patients with inflammatory bowel disease treated with ustekinumab but not vedolizumab

Clinical Response for 12 Months or More to the First Advanced Therapy is Associated with a Significant Decrease in the Long-Term Risk of Hospitalization: A Nation-Wide Analysis of Patients From the UK Inflammatory Bowel Disease (IBD) BioResource

Clinical Outcome After Entero-Enteric Anastomosis for Crohn's Disease: A Case-Control Study

Effectiveness, Durability, and Safety of Ustekinumab in Inflammatory Bowel Disease: Results from the Taiwan Multicenter Real-world Ustekinumab Study (T-RUST Study)

Efficacy, safety, and outcomes of endoscopic submucosal dissection for inflammatory bowel disease-associated colorectal neoplasia: a systematic review and meta-analysis comparing Asian and Western outcomes

Serious infections in patients with inflammatory bowel disease and corticosteroids: A propensity score-matched study